Valery Adorno-Cruz Selected Research

Phenobarbital (Luminal)

1/2018

Cx26 drives self-renewal in triple-negative breast cancer via interaction with NANOG and focal adhesion kinase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Valery Adorno-Cruz Research Topics

Disease

11	Neoplasms (Cancer) 04/2023 - 03/2015
9	Neoplasm Metastasis (Metastasis) 04/2023 - 03/2015
7	Breast Neoplasms (Breast Cancer) 04/2023 - 02/2017
5	Triple Negative Breast Neoplasms 01/2023 - 01/2018
1	Circulating Neoplastic Cells 01/2023
1	Leukemia 02/2017
1	Inflammation (Inflammations) 03/2015

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 10/2022 - 11/2021
2	IntegrinsIBA 07/2021 - 03/2019
2	MicroRNAs (MicroRNA)IBA 07/2021 - 02/2017
2	Biomarkers (Surrogate Marker)IBA 07/2021 - 01/2019
1	LigandsIBA 04/2023
1	Glycoproteins (Glycoprotein)IBA 01/2023
1	Neutralizing AntibodiesIBA 01/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2023
1	TetraspaninsIBA 10/2022
1	RNA (Ribonucleic Acid)IBA 11/2021
1	tivozanibIBA 10/2021
1	PlatinumIBA 10/2021
1	Estrogen ReceptorsIBA 07/2021
1	AntibodiesIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Integrin alpha2beta1IBA 03/2019
1	ConnexinsIBA 01/2018
1	Phenobarbital (Luminal)FDA Link 01/2018
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2018
1	human MIRN206 microRNAIBA 02/2017
1	Transcription Factors (Transcription Factor)IBA 02/2017
1	Interleukin-11 (Interleukin 11)IBA 02/2017
1	Serum Response FactorIBA 02/2017
1	hydroxide ionIBA 03/2015

Therapy/Procedure

4	Therapeutics 01/2023 - 03/2015
1	Drug Therapy (Chemotherapy) 01/2023